Instrument Inactif

Autres langues Parnell Pharmaceuticals Holdings Ltd Other OTC

Actions

PARNF

AU0000XINEU9

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Parnell Pharmaceuticals : Introduces Two New Sedation Products to Pet Care Product Line	15/05
Parnell Pharmaceuticals : Welcomes Dr. Chelsie Estey as Vice President of U.S. Pet Care	07/03
Parnell Pharmaceuticals : Adds Three Experts to Leadership Team	31/05/23
Parnell Pharmaceuticals : Two New Territory Business Managers Help Parnell Better Serve Producers and Veterinarians	31/05/23
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering	06/01/23
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering	07/12/22
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum	21/06/22
Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	21/06/22
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners completed the acquisition of a 29% stake in Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $2.5 million	28/01/21
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners made an offer to acquire Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $7.2 million.	21/12/20
Parnell Pharmaceuticals Announces Nomovid Antiviral Nasal Spray	23/09/20
Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	14/10/19
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Full Year Ended 31 December 2018; Provides Earnings Guidance for the Year 2019	05/04/19
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2018; Revises Revenue Guidance for the Year 2018	02/11/18
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018; Revised Earnings Guidance for the Full Year 2018	03/08/18
Parnell Pharmaceuticals Holdings Ltd Reports Audited Earnings Results for the First Quarter Ended March 31, 2018; Revises Earnings Guidance for the Year 2018	28/04/18
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Earnings Guidance for the Year 2017	17/08/17
Certain Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	30/03/17
Certain Options of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	30/03/17
Certain Warrants of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	30/03/17

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Parnell Pharmaceuticals Holdings Ltd Other OTC

Actions

PARNF

AU0000XINEU9

Autres langues

Filtres